Literature DB >> 2166137

The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

C J Vecht1, C J Avezaat, W L van Putten, W M Eijkenboom, S Z Stefanko.   

Abstract

A retrospective analysis was performed on 66 patients with anaplastic astrocytoma (AA) and 177 patients with glioblastoma multiforme (GM). The prognostic importance of age, performance status, tumour location, extent of surgery and radiation treatment was studied. Radiation therapy gave a significant improvement in survival in both AA (p less than 0.003) and GM (p less than 0.002), but was given only to patients in a good neurological condition. Both younger age (p less than 0.003), and good preoperative performance status (p less than 0.002) were associated with a longer survival in AA, but not in GM. Extensive surgery was correlated with a better immediate postoperative performance, a lower one-month mortality rate and a longer survival, in both AA and GM. There was no relationship between preoperative neurological function status and the extent of surgery. Because of the retrospective nature of this study, the conclusion is that performing extensive surgery instead of limited surgery does not lead to more deterioration in postoperative neurological function.

Entities:  

Mesh:

Year:  1990        PMID: 2166137      PMCID: PMC1014204          DOI: 10.1136/jnnp.53.6.466

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Glioblastoma multiforme: a clinical survey.

Authors:  J G ROTH; A R ELVIDGE
Journal:  J Neurosurg       Date:  1960-07       Impact factor: 5.115

2.  The treatment of glioblastoma multiforme of the brain.

Authors:  R Jelsma; P C Bucy
Journal:  J Neurosurg       Date:  1967-11       Impact factor: 5.115

3.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group.

Authors:  B Borgelt; R Gelber; S Kramer; L W Brady; C H Chang; L W Davis; C A Perez; F R Hendrickson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-01       Impact factor: 7.038

4.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

5.  Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.

Authors:  K Kristiansen; S Hagen; T Kollevold; A Torvik; I Holme; R Nesbakken; R Hatlevoll; M Lindgren; A Brun; S Lindgren; G Notter; A P Andersen; K Elgen
Journal:  Cancer       Date:  1981-02-15       Impact factor: 6.860

6.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

7.  Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

Authors:  S B Green; D P Byar; M D Walker; D A Pistenmaa; E Alexander; U Batzdorf; W H Brooks; W E Hunt; J Mealey; G L Odom; P Paoletti; J Ransohoff; J T Robertson; R G Selker; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  Cancer Treat Rep       Date:  1983-02

8.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.

Authors:  C H Chang; J Horton; D Schoenfeld; O Salazer; R Perez-Tamayo; S Kramer; A Weinstein; J S Nelson; Y Tsukada
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

9.  CT prognostic criteria of survival after malignant glioma surgery.

Authors:  J Andreou; A E George; A Wise; M de Leon; I I Kricheff; J Ransohoff; S H Foo
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

10.  Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.

Authors:  J S Nelson; Y Tsukada; D Schoenfeld; K Fulling; J Lamarche; N Peress
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

View more
  48 in total

1.  Extent of resection in malignant gliomas: a critical summary.

Authors:  R Sawaya
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

3.  Cancer treatment - objectives and quality of life issues.

Authors:  Farhat Aziz Khan; Shad Salim Akhtar; Muhammad Kamil Sheikh
Journal:  Malays J Med Sci       Date:  2005-01

Review 4.  The treatment of primary malignant brain tumours.

Authors:  I R Whittle; A Gregor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

5.  Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery.

Authors:  Timothy C Ryken; Bruce Frankel; Terrance Julien; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

Review 6.  Operative techniques for gliomas and the value of extent of resection.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

7.  Correlation of intra-operative ultrasound with histopathologic findings after tumour resection in supratentorial gliomas. A method to improve gross total tumour resection.

Authors:  M Woydt; A Krone; G Becker; K Schmidt; W Roggendorf; K Roosen
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model.

Authors:  Pablo A Valdés; Kimberley Samkoe; Julia A O'Hara; David W Roberts; Keith D Paulsen; Brian W Pogue
Journal:  Photochem Photobiol       Date:  2009-12-07       Impact factor: 3.421

9.  Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.

Authors:  Uwe Pichlmeier; Andrea Bink; Gabriele Schackert; Walter Stummer
Journal:  Neuro Oncol       Date:  2008-07-30       Impact factor: 12.300

10.  Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatment.

Authors:  C Balaña; J Capellades; P Teixidor; I Roussos; R Ballester; M Cuello; A Arellano; R Florensa; R Rosell
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.